Rentokil Initial Plc. ADR (NYSE:RTO) does about 540.17K shares in volume on a normal day but saw 1017999 shares change hands in the recent trading day. The company now has a market cap of 14.80B USD. Its current market price is $29.46, marking a decrease of -1.07% compared to the previous close of $29.78. The 52 week high reached by this stock is $39.62 whilst the lowest price level in 52 weeks is $23.39. The script in recent trading has seen the stock touch a high of $35 and a low of $35.
Rentokil Initial Plc. ADR (RTO) has a 20-day trading average at $30.47 and the current price is -25.64% off the 52-week high compared with 25.95% distance from its 52-week low. The 50-day simple moving average of the closing price is $29.40 and its 200-day simple moving average is $28.03. If we look at the stock’s price movements over the week, volatility stands at 2.36%, which decreases to 1.59% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 44.82 to suggest the stock is neutral.
The consensus objective for the share price is $34.80, suggesting that the stock has a potential upside of 15.34% over the period. The median price target is 15.83% away from the current levels at $35.
1 analysts have rated it as a buy and 2 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Moderate Buy the stock.
BofA Securities downgraded its price target at $40-$29.
Rentokil Initial Plc. ADR (RTO) stock is down -3.82% over the week and -3.09% over the past month. Its price is 2.97% year-to-date and -23.22% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0.0 for whole year.
Its 12-month price target is $35. To reach the target analysts have set, the stock logically needs to grow 15.34 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $35, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $35.
The company has a return on investment of 5.15% and return on equity of 9.59%. The price to earnings ratio (P/E ratio) amounts to 30.19 while the forward price to earnings ratio is 17.64. The beta has a value of 1.10. Price to book ratio is 2.81 and price to sales ratio is 2.17.
